Haemonetics (HAE) Other Accumulated Expenses (2010 - 2026)

Haemonetics' Other Accumulated Expenses history runs 17 years deep, the most recent figure standing at $158.3 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 6.89% year-over-year to $158.3 million; the TTM figure through Mar 2026 stood at $158.3 million (up 6.89% YoY), while the FY2026 annual figure was $158.3 million, up 6.89% from the prior year.
• Other Accumulated Expenses was $158.3 million for Q1 2026 at Haemonetics, up from $134.3 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $158.3 million in Q1 2026 to a low of $85.3 million in Q3 2022.
• Historically, Other Accumulated Expenses has averaged $127.3 million across 5 years, with a median of $133.2 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses slumped 33.26% in 2022, then surged 31.6% in 2023.
• A 5-year view of Other Accumulated Expenses shows it stood at $101.0 million in 2022, then soared by 31.12% to $132.4 million in 2023, then climbed by 5.15% to $139.2 million in 2024, then slipped by 3.52% to $134.3 million in 2025, then rose by 17.87% to $158.3 million in 2026.
• The last three Other Accumulated Expenses figures came in at $158.3 million (Q1 2026), $134.3 million (Q4 2025), and $134.0 million (Q3 2025), per Business Quant data.